Amy Meysner

摘要

Amy Meysner, a British specialist in ICP-OES analytical techniques who manages the chemistry department at Glass Technology Services (GTS) in the UK, tells me her professional background builds on a degree in Forensic Bioscience, and I can't help but pick her brain to disect the good, the bad, and the ugly in today's primary packaging in the pharmaceutical industry. For Meysner, the changes seen today in the pharmaceutical glass packaging market have been partly driven by the negative press coverage of high-profile recalls in 2010-2011 due to suspected delamination, and the following FDA advisory to drug manufacturers regarding the problem.